129 related articles for article (PubMed ID: 12629938)
1. Cardiotoxicity and capecitabine: a case report.
Singer M
Clin J Oncol Nurs; 2003; 7(1):72-5. PubMed ID: 12629938
[TBL] [Abstract][Full Text] [Related]
2. Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.
Le Brun-Ly V; Martin J; Venat-Bouvet L; Darodes N; Labourey JL; Genet D; Tubiana-Mathieu N
Oncology; 2009; 76(5):322-5. PubMed ID: 19307737
[TBL] [Abstract][Full Text] [Related]
3. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
O'Shaughnessy JA; Blum JL
Clin Breast Cancer; 2006 Apr; 7(1):42-50. PubMed ID: 16764743
[TBL] [Abstract][Full Text] [Related]
7. [Myocardial ischaemia as a result of treatment with capecitabine].
van Halteren HK; Liem AH; Planting AS
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)].
Mallmann P; Nitschmann S
Internist (Berl); 2010 Jul; 51(7):923-4. PubMed ID: 20544172
[No Abstract] [Full Text] [Related]
9. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.
Frickhofen N; Beck FJ; Jung B; Fuhr HG; Andrasch H; Sigmund M
Ann Oncol; 2002 May; 13(5):797-801. PubMed ID: 12075751
[TBL] [Abstract][Full Text] [Related]
10. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
[TBL] [Abstract][Full Text] [Related]
12. Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine.
Trindade F; Haro R; Fariña MC; Requena L
Am J Dermatopathol; 2008 Apr; 30(2):172-3. PubMed ID: 18360124
[TBL] [Abstract][Full Text] [Related]
13. Acute cardiotoxicity during capecitabine treatment: a case report.
Bertolini A; Flumanò M; Fusco O; Muffatti A; Scarinci A; Pontiggia G; Scopelliti M
Tumori; 2001; 87(3):200-6. PubMed ID: 11504378
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine-induced hypertriglyceridemia: a report of two cases.
Koutras AK; Habeos IG; Vagenakis AG; Kalofonos HP
Anticancer Res; 2006; 26(3B):2249-51. PubMed ID: 16821596
[TBL] [Abstract][Full Text] [Related]
15. Coronary spasm induced by capecitabine.
Schnetzler B; Popova N; Collao Lamb C; Sappino AP
Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636
[No Abstract] [Full Text] [Related]
16. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
17. Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?
Kurt M; Aksoy S; Guler N
Acta Oncol; 2006; 45(5):625-6. PubMed ID: 16864181
[No Abstract] [Full Text] [Related]
18. A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.
Rocca A; Maltoni R; Passardi A; Massa I; Aquilina M; Ridolfi R; Ibrahim T; Cecconetto L; Sarti S; Pietri E; Nanni O; Amadori D
Cancer Chemother Pharmacol; 2010 Apr; 65(5):871-6. PubMed ID: 19693503
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine cardiac toxicity presenting as effort angina: a case report.
Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
[TBL] [Abstract][Full Text] [Related]
20. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
